Health Care Technology
Painteq Scales Leadership: Med-Tech Catalyst Robert Kline Joins Board To Drive New Standard In Interventional Spine Care
Share
TAMPA, Fla., Oct. 28, 2025 /PRNewswire/ -- Med-tech veteran Robert Kline has joined the Board of Directors at PainTEQ, a strategic move to capitalize on his commercialization and growth expertise as the company redefines interventional spine care.
Building on a 25-year history of commercializing groundbreaking medical devices, Kline will now focus on propelling PainTEQ's expansion and further establishing the company's market leadership. His background includes:
- Founder of Medivance, a pioneer in therapeutic temperature management, acquired by C. R. Bard (now Becton Dickinson) in 2011.
- Co-founder of ViroCyt, a technology firm acquired by Sartorius AG in 2016.
- Former CEO of Bolder Surgical, acquired by Hologic, Inc. for $160 million in 2021.
Following a growth recapitalization, the addition of Kline's strategic guidance strongly positions PainTEQ to accelerate the expansion and adoption of its LinQ system. Kline brings a unique synergy, rooted in his proven history at Bolder Surgical of commercializing minimally invasive solutions that significantly reduce the need for high-risk, complex surgeries.
"PainTEQ has a clear and essential vision for the market," said Robert Kline. "My decision to join the PainTEQ board was based on a simple fact: the LinQ system works. It provides superior patient outcomes in a highly efficient manner—the gold standard for med-tech innovation."
Shanth Thiyagalingam, PainTEQ CEO, stated: "Robert Kline's expertise gives us a powerful strategic advantage, enabling us to expand our mission of clinical excellence built on evidence-backed medicine. With his guidance, we will accelerate responsible adoption and raise the standard of care."
PainTEQ's flagship LinQ® SI Joint Stabilization System has provided relief in over 14,000 procedures. Unlike traditional, more invasive surgery, LinQ's single-implant, posterior approach results in a quicker recovery, less tissue damage, and shorter procedure time, helping patients get back to their lives faster.
David Kereiakes, Managing Partner at Windham Capital Partners, and PainTEQ board member, added: "I have long admired and benefited from Robert's leadership and talent for driving results. He is an invaluable addition to the team."
About PainTEQ: PainTEQ was built to bring interventional procedures to the market. Working with pain management specialists to help reduce and eliminate SI joint dysfunction, PainTEQ's LinQ implant and single-use instruments aim to immediately provide clinical benefits to individuals living with incapacitating lower back pain through a minimally invasive outpatient procedure. Learn more at www.painteq.com
About LinQ: The LinQ SI Joint Stabilization System provides patients with a minimally invasive option to combat pain due to sacroiliac disease. After a thorough diagnostic process, physicians may help alleviate – and in many cases eliminate – chronic pain by placing a single LinQ allograft into the SI joint. With its large graft window, the LinQ implant is designed to create an ideal environment for long-term fusion.
View original content to download multimedia:https://www.prnewswire.com/news-releases/painteq-scales-leadership-med-tech-catalyst-robert-kline-joins-board-to-drive-new-standard-in-interventional-spine-care-302596188.html
SOURCE PainTEQ
Frequently Asked Questions
What is the LinQ SI Joint Stabilization System?
The LinQ SI Joint Stabilization System is a minimally invasive option for patients suffering from pain due to sacroiliac disease. It involves placing a single LinQ allograft into the SI joint to alleviate chronic pain.
What are the benefits of the LinQ system compared to traditional surgery?
LinQ offers a quicker recovery, less tissue damage, and shorter procedure time compared to traditional, more invasive surgery, allowing patients to return to their lives faster.
Who is Robert Kline and what is his role at PainTEQ?
Robert Kline is a med-tech veteran who has joined PainTEQ's Board of Directors. He will focus on propelling PainTEQ's expansion and further establishing the company's market leadership.
First published on Tue, Oct 28, 2025
Enjoyed what you've read so far? Great news - there's more to explore!
Stay up to date with the latest news, a vast collection of tech articles including introductory guides, product reviews, trends and more, thought-provoking interviews, hottest AI blogs and entertaining tech memes.
Plus, get access to branded insights such as informative white papers, intriguing case studies, in-depth reports, enlightening videos and exciting events and webinars from industry-leading global brands.
Dive into TechDogs' treasure trove today and Know Your World of technology!
Disclaimer - Reference to any specific product, software or entity does not constitute an endorsement or recommendation by TechDogs nor should any data or content published be relied upon. The views expressed by TechDogs' members and guests are their own and their appearance on our site does not imply an endorsement of them or any entity they represent. Views and opinions expressed by TechDogs' Authors are those of the Authors and do not necessarily reflect the view of TechDogs or any of its officials. While we aim to provide valuable and helpful information, some content on TechDogs' site may not have been thoroughly reviewed for every detail or aspect. We encourage users to verify any information independently where necessary.
Trending PR Newswire
Protecting Print Fleets: Symphion Addresses Complacency In Printer Endpoint Protection With Two New Offerings
School Specialty LLC Announces Acquisition Of Nasco Education U.S.
Scowtt Raises $12M Series A To Transform Performance Marketing With AI-Powered Advertising Platform
Unified.To Powers 550% API Usage Growth In Six Months Amid Rising AI Adoption
Broadridge's Distributed Ledger Repo Platform Processes $368 Billion In Average Daily Trade Volumes In November
Join Our Newsletter
Get weekly news, engaging articles, and career tips-all free!
By subscribing to our newsletter, you're cool with our terms and conditions and agree to our Privacy Policy.
Join The Discussion